RXO (NYSE: $RXO) Surges +20% Toward $30.25 on C.H. Robinson Acquisition (Check any stock’s price target on Tickeron.) The central target is $30.25 per share — the implied value of C.H. Robinson's agreed cash-and-stock acquisition of RXO, not an analyst consensus. The figure comes from the merger agreement: $17.25 in cash plus 0.0856 C.H. Robinson shares for each RXO share. RXO shares jumped roughly 20–23% on the news, trading near $28.86 versus an October 2 close of $23.38, leaving a modest gap of about 5% to the $30.25 deal value. Pre-deal analyst price targets, which clustered roughly between $10 and $23 (averaging in the mid-teens in late 2025), are now largely superseded by the buyout. The strongest supports are unanimous board approval and backing from RXO's largest holders; the biggest risks are antitrust clearance and C.H. Robinson's share price, which funds 43% of the consideration. $CVLG $HTLD $ARCB $WERN $SAIA